Virus-like particles (VLPs) are protein-based structures that mimic viruses and bind to antibodies. Because VLPs aren’t infectious, they show promise as vaccine platforms for many viral diseases, including influenza. Since details about influenza VLPs are scant, a team of researchers developed a 3-D model based on the 1918 H1 pandemic influenza virus.